FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32762111000001104: Descovy 200mg/25mg tablets (Gilead Sciences Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jun 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1841071000001114 Descovy 200mg/25mg tablets (Gilead Sciences Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1841081000001111 Descovy 200mg/25mg tablets (Gilead Sciences Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Is a Emtricitabine 200mg / Tenofovir 25mg tablets true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has specific active ingredient Tenofovir alafenamide fumarate false Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide false Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Is a Descovy true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has active ingredient Tenofovir true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Has specific active ingredient Tenofovir alafenamide fumarate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Descovy 200mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has AMP True Descovy 200mg/25mg tablets (Gilead Sciences Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start